½Äǰ Áø´Ü¿ë PCR ½Ã½ºÅÛ ½ÃÀåÀº 2023-2028³â°£ 9¾ï 5,959¸¸ ´Þ·¯ È®´ëµÇ°í, ¿¹Ãø ±â°£ Áß ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 8.73%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
½Äǰ Áø´Ü¿ë PCR ½Ã½ºÅÛ ½ÃÀå¿¡ ´ëÇÑ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´ë»óÀ¸·Î ÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ °ÔÀçÇß½À´Ï´Ù.
ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ½ÄÁßµ¶ Áõ°¡, ¼¼°è¿¡ ½Äǰ ¾ÈÀüÀ» Á¦Ã¢ÇÏ´Â Á¶Á÷, ½Äǰ ¾ÈÀü±âÁØÀÇ Á߿伺 Áõ°¡ µîÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§ |
±âÁسâ |
2024 |
Á¾·á³â |
2028 |
¿¹Ãø ±â°£ |
2024-2028 |
¼ºÀå ¸ð¸àÅÒ |
°¡¼Ó |
YOY 2024 |
8.04% |
CAGR |
8.73% |
ÁõºÐ¾× |
9¾ï 5,959¸¸ ´Þ·¯ |
º» Á¶»ç¿¡¼´Â ÇâÈÄ ¸î ³â°£ ½Äǰ Áø´Ü¿ë PCR ½Ã½ºÅÛ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿äÀÎ Áß Çϳª·Î¼ ½Äǰ ¾ÈÀü¼º¿¡ °üÇÑ ¼ÒºñÀÚ ÀǽÄÀÇ °í¾çÀ» µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ PCR ½Ã½ºÅÛ ±â¼ú ¹ßÀü, °Ë»ç ±â¼ú Çâ»ó°ú ½ÃÀå °³Ã´ÀÌ ½ÃÀåÀÇ Å« ¼ö¿ä·Î ¿¬°áµÉ °ÍÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå ±¸µµ
Á¦3Àå ½ÃÀå ±Ô¸ð
- ½ÃÀåÀÇ Á¤ÀÇ
- ½ÃÀå ºÎ¹® ºÐ¼®
- ½ÃÀå ±Ô¸ð(2023³â)
- ½ÃÀå Àü¸Á(2023-2028³â)
Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû
- ¼¼°èÀÇ ½Äǰ Áø´Ü¿ë PCR ½Ã½ºÅÛ ½ÃÀå(2018-2022³â)
- ¿ëµµº° ºÎ¹® ºÐ¼®(2018-2022³â)
- Á¦Ç°º° ºÎ¹® ºÐ¼®(2018-2022³â)
- Áö¿ªº° ºÎ¹® ºÐ¼®(2018-2022³â)
- ±¹°¡º° ºÎ¹® ºÐ¼®(2018-2022³â)
Á¦5Àå Five Forces ºÐ¼®
- Five Forces ¿ä¾à
- ¹ÙÀ̾îÀÇ ±³¼··Â
- °ø±Þ ±â¾÷ÀÇ ±³¼··Â
- ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
- ´ëüǰÀÇ À§Çù
- °æÀï À§Çù
- ½ÃÀå ÇöȲ
Á¦6Àå ½ÃÀå ¼¼ºÐÈ : ¿ëµµº°
- ½ÃÀå ºÎ¹®
- ºñ±³ : ¿ëµµº°
- °¡Á¤¿ë : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
- »ó¾÷¿ë : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
- ½ÃÀå ±âȸ : ¿ëµµº°
Á¦7Àå ½ÃÀå ¼¼ºÐÈ : Á¦Ç°º°
- ½ÃÀå ºÎ¹®
- ºñ±³ : Á¦Ç°º°
- ¼Ò¸ðǰ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
- ±â±â : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
- ½ÃÀå ±âȸ : Á¦Ç°º°
Á¦8Àå °í°´ »óȲ
Á¦9Àå Áö¿ªº° »óȲ
- Áö¿ªº° ¼¼ºÐÈ
- Áö¿ªº° ºñ±³
- ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
- À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
- ¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
- ¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
- ¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
- µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
- ¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
- ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
- ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
- ½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦10Àå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦ ¹× µ¿Çâ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
- ¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
- ½ÃÀå µ¿Çâ
Á¦11Àå º¥´õ ±¸µµ
- °³¿ä
- º¥´õ ±¸µµ
- È¥¶õ »óȲ
- ¾÷°è ¸®½ºÅ©
Á¦12Àå º¥´õ ºÐ¼®
- ´ë»ó º¥´õ
- º¥´õÀÇ ½ÃÀå Æ÷Áö¼Å´×
- Agilent Technologies Inc.
- Bio Rad Laboratories Inc.
- bioMerieux SA
- EW Group GmBH
- Lumex Instruments
- LuminUltra Technologies Ltd
- Merck and Co. Inc.
- Microsynth AG
- Molbio Diagnostics Pvt. Ltd.
- QIAGEN NV
- QuantuMDx Group Ltd.
- R Biopharm AG
- SAN Group GmbH
- Thermo Fisher Scientific Inc.
- Xiamen Zeesan Biotech Co. Ltd.
Á¦13Àå ºÎ·Ï
LSH
The PCR system for food diagnostics market is forecasted to grow by USD 959.59 mn during 2023-2028, accelerating at a CAGR of 8.73% during the forecast period. The report on the PCR system for food diagnostics market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising foodborne illnesses, organizations advocating food safety globally, and the growing importance of food safety standards.
Technavio's PCR system for food diagnostics market is segmented as below:
Market Scope |
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 8.04% |
CAGR | 8.73% |
Incremental Value | $959.59mn |
By Application
By Product
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing consumer awareness about food safety as one of the prime reasons driving the PCR system for food diagnostics market growth during the next few years. Also, advances in technology in PCR systems and rising improvisation and development of testing technology will lead to sizable demand in the market.
The report on the PCR system for food diagnostics market covers the following areas:
- Pcr system for food diagnostics market sizing
- Pcr system for food diagnostics market forecast
- Pcr system for food diagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading PCR system for food diagnostics market vendors that include Agilent Technologies Inc., Bio Rad Laboratories Inc., bioMerieux SA, EW Group GmBH, Generon SpA, Genesystem, Lumex Instruments, LuminUltra Technologies Ltd, Merck and Co. Inc., Microsynth AG, Minerva Biolabs GmbH, Molbio Diagnostics Pvt. Ltd., Mylab Discovery Solutions Pvt Ltd., PerkinElmer Inc, QIAGEN NV, QuantuMDx Group Ltd., R Biopharm AG, SAN Group GmbH, Thermo Fisher Scientific Inc., and Xiamen Zeesan Biotech Co. Ltd.. Also, the PCR system for food diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
- 3.1 Market definition
- 3.2 Market segment analysis
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
4 Historic Market Size
- 4.1 Global PCR system for food diagnostics market 2018 - 2022
- 4.2 Application Segment Analysis 2018 - 2022
- 4.3 Product Segment Analysis 2018 - 2022
- 4.4 Geography Segment Analysis 2018 - 2022
- 4.5 Country Segment Analysis 2018 - 2022
5 Five Forces Analysis
- 5.1 Five forces summary
- 5.2 Bargaining power of buyers
- 5.3 Bargaining power of suppliers
- 5.4 Threat of new entrants
- 5.5 Threat of substitutes
- 5.6 Threat of rivalry
- 5.7 Market condition
6 Market Segmentation by Application
- 6.1 Market segments
- 6.2 Comparison by Application
- 6.3 Household - Market size and forecast 2023-2028
- 6.4 Commercial - Market size and forecast 2023-2028
- 6.5 Market opportunity by Application
7 Market Segmentation by Product
- 7.1 Market segments
- 7.2 Comparison by Product
- 7.3 Consumables - Market size and forecast 2023-2028
- 7.4 Instruments - Market size and forecast 2023-2028
- 7.5 Market opportunity by Product
8 Customer Landscape
- 8.1 Customer landscape overview
9 Geographic Landscape
- 9.1 Geographic segmentation
- 9.2 Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- 9.4 Europe - Market size and forecast 2023-2028
- 9.5 Asia - Market size and forecast 2023-2028
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- 9.7 US - Market size and forecast 2023-2028
- 9.8 Germany - Market size and forecast 2023-2028
- 9.9 UK - Market size and forecast 2023-2028
- 9.10 France - Market size and forecast 2023-2028
- 9.11 Canada - Market size and forecast 2023-2028
- 9.12 Market opportunity By Geographical Landscape
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- 11.3 Landscape disruption
- 11.4 Industry risks
12 Vendor Analysis
- 12.1 Vendors covered
- 12.2 Market positioning of vendors
- 12.3 Agilent Technologies Inc.
- 12.4 Bio Rad Laboratories Inc.
- 12.5 bioMerieux SA
- 12.6 EW Group GmBH
- 12.7 Lumex Instruments
- 12.8 LuminUltra Technologies Ltd
- 12.9 Merck and Co. Inc.
- 12.10 Microsynth AG
- 12.11 Molbio Diagnostics Pvt. Ltd.
- 12.12 QIAGEN NV
- 12.13 QuantuMDx Group Ltd.
- 12.14 R Biopharm AG
- 12.15 SAN Group GmbH
- 12.16 Thermo Fisher Scientific Inc.
- 12.17 Xiamen Zeesan Biotech Co. Ltd.
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- 13.3 Currency conversion rates for US$
- 13.4 Research methodology
- 13.5 List of abbreviations